Koninklijke Philips N.V. (PHG) Stock Price & Analysis
Koninklijke Philips N.V. (PHG) — MoonshotScore 78/100 (Strong band), calculated Nov 18, 2026. Price $29.27 (-1.81%), as of the Nov 19, 2026 trading session; market cap $28.6B.
Educational signal · not a buy or sell recommendation · How to read this
Koninklijke Philips N.V. · PHG · NYSE · Healthcare · Medical - Devices
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · Koninklijke Philips (PHG)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and durable growth, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.
- quarterly revenue €4.37B (Q3 FY2026, quarter ended Sep 2026)
- EPS beat 6 of the last 8 reports
- Altman Z 2.07 · Piotroski F 7
Helping: business quality, an attractive price, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 76 | Strong | |
| 77 | Strong | |
| 77 | Strong | |
| 77 | Strong | |
| 78 | Strong | |
| 78 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $29.27 | |
| Change on the day | -1.81% | |
| 52-week range | $23.62–$33.44 | |
| Market capitalisation | $28.6B | — |
| Price / earnings (trailing) | 26.96 | |
| Shares traded on the day | 1.46M | |
| Beta (volatility vs the S&P 500) | 0.92 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Koninklijke Philips (PHG): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Koninklijke Philips (PHG), and what does it report?
Short answer
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. Koninklijke Philips N.V. (PHG) is listed on NYSE. Healthcare / Medical Devices SEC filing business address: Prinses Irenestraat 59, Amsterdam, 1077WV. It employs 66,401 people and is led by Roy W. O. Jakobs. In Q3 FY2026 it reported revenue of €4.37B and net income of €27M. The market values it at $28.6B.
What do the latest results show for Koninklijke Philips (PHG)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of €4.37B. Against analyst estimates the company has EPS beat 6 of the last 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | €4.37B | €27M | €0.03 (diluted) |
| Q2 FY2026 | €4.36B | €384M | €0.40 (diluted) |
| Q1 FY2026 | €3.90B | €151M | €0.16 (diluted) |
| Q4 FY2025 | €5.10B | €395M | €0.41 (diluted) |
What are the financial strengths and risks for Koninklijke Philips (PHG)?
Short answer · as of
The MoonshotScore pillars rate business quality, an attractive price, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.07 · Piotroski F 7. Trailing ratios: ROE 8.4% · ROA 3.4% · current ratio 1.33 · earnings yield 3.6% · free-cash-flow yield 7.8%.
How does Koninklijke Philips compare with its peers?
Short answer
Koninklijke Philips's score ranks 10th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12.
Unlike a focused hospital equipment vendor, Philips combines diagnostic and treatment platforms with monitoring, respiratory care, enterprise informatics, and branded consumer health products. Its results therefore reflect purchasing by health systems as well as demand for oral care, personal care, and mother-and-child products.
That breadth makes product mix economically important: which Philips products sell matters alongside how much the company sells. Management's warning about unfavorable mix confirms that shifts within the portfolio can pressure margins even without a broad revenue contraction.
| Company | Price | Market value | Score |
|---|---|---|---|
| $80.19 Nov 19, 2026 | $29.9B | 93 5-pillar Nov 18, 2026 | |
| $1737.26 Nov 18, 2026 | $34.6B | 93 5-pillar Nov 18, 2026 | |
| $105.23 Nov 18, 2026 | $60.5B | 93 5-pillar Nov 18, 2026 | |
| $320.00 Nov 19, 2026 | $12.6B | 92 5-pillar Nov 18, 2026 | |
| $259.57 Nov 18, 2026 | $25.2B | 87 5-pillar Nov 18, 2026 | |
| $139.98 Nov 18, 2026 | $9.71B | 85 5-pillar Nov 18, 2026 | |
| $30.32 Nov 18, 2026 | $12.7B | 84 5-pillar Nov 18, 2026 | |
| $163.96 Nov 18, 2026 | $11.6B | 83 5-pillar Nov 18, 2026 | |
| $103.32 Nov 18, 2026 | $19.6B | 79 5-pillar Nov 18, 2026 | |
| Koninklijke Philips (PHG) — this page | $29.27 | $28.6B | 78 |
| $43.64 Nov 18, 2026 | $63.3B | 77 5-pillar Nov 18, 2026 | |
| $370.17 Nov 18, 2026 | $9.95B | 77 5-pillar Nov 18, 2026 | |
| $42.23 Nov 18, 2026 | $49.3B | 57 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held PHG in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported PHG in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Koninklijke Philips (PHG)?
- Philips Unveils Skylight Device Manager to Boost Ultrasound Efficiency
- Global Clinical-Grade Wearables for Pharma and Biotech Market Report 2026 | Capitalize on 21.5% CAGR to $7.48B by 2030 as Abbott, Medtronic, DexCom and Philips Scale AI-Driven RPM
- Virtual Clinics Market Global Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 13% CAGR as Optum, Cigna, Teladoc Health, and Philips Scale AI-Driven Hybrid Care
- Philips Selects ChannelEngine to Expand Marketplace Operations in Europe
What Investors Ask About Koninklijke Philips (PHG) — Healthcare
Research dated 2026-09-12; the full attribution is under Sources. The last question is answered from this page's own dated data, not from the research.
What does Philips sell beyond diagnosis and treatment systems?
Philips also supplies patient monitoring, sleep and respiratory care, and enterprise informatics, while Personal Health covers oral care, personal care, and mother-and-child products.
What is pressuring Philips adjusted margin?
Management identifies input-cost inflation, annualized tariffs, and an unfavorable product mix as offsets to innovation, productivity, and sales growth.
How does Philips Personal Health change its business exposure?
Personal Health adds oral care, personal care, and mother-and-child products to a portfolio otherwise centered on hospital systems, clinical devices, software, and care services. Philips is therefore not a pure hospital-equipment business.
What is the PHG stock price today?
The last price recorded for Koninklijke Philips N.V. (PHG), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 20 figures on this page — 1 from SEC filings and earnings calls, 14 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources (as of 2026-09-12), by section of the research
ETFs that hold PHG
Funds in our ETF coverage that list PHG among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| LGHT ETF | 6.53% |